Back to Business

U.S. FDA issues observation to Aurobindo Pharma arm’s API unit

Business September 15, 2026 at 3:14 PM

U.S. FDA issues observation to Aurobindo Pharma arm’s API unit

The Hindu Business

Read at The Hindu Business

More Stories

Flipkart creates 2.5 lakh festive-season jobs, 75,000 for first-time entrants

Flipkart creates 2.5 lakh festive-season jobs, 75,000 for first-time entrants

New opportunities to span 7,000-plus Ekart facilities; 60% of hiring to be in last-mile delivery.

🇮🇳 The Hindu Business 21m ago

Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler

Aurobindo Pharma wins U.S. FDA approval for generic asthma inhaler

The product will be manufactured at subsidiary Aurolife Pharma’s Raleigh facility in North Carolina and expected to be l…

🇮🇳 The Hindu Business 1h ago

US 10-year Treasury yield rises to highest since 2007 as Fed rate hike bets strengthen

US 10-year Treasury yield rises to highest since 2007 as Fed rate hike bets strengthen

The US 10-year Treasury yield has reached 5.041%, the highest since July 2007, as rising crude oil prices bolster expect…

🇮🇳 Livemint Markets 1h ago

Your world briefing, in your pocket

AI-curated news from 12 countries and 10 languages — coming soon on iOS and Android.

Coming soon on App Store Coming soon on Google Play